Huntington National Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.6K | Sell |
195
-3
| -2% | -$978 | ﹤0.01% | 1150 |
|
|
2025
Q1 | $53.5K | Buy |
198
+125
| +171% | +$33.8K | ﹤0.01% | 1152 |
|
|
2024
Q4 | $17.2K | Sell |
73
-21
| -22% | -$4.94K | ﹤0.01% | 1587 |
|
|
2024
Q3 | $25.9K | Buy |
94
+45
| +92% | +$12.4K | ﹤0.01% | 1429 |
|
|
2024
Q2 | $11.9K | Sell |
49
-18
| -27% | -$4.37K | ﹤0.01% | 1629 |
|
|
2024
Q1 | $10K | Buy |
67
+35
| +109% | +$5.23K | ﹤0.01% | 1678 |
|
|
2023
Q4 | $6.13K | Buy |
32
+2
| +7% | +$383 | ﹤0.01% | 1822 |
|
|
2023
Q3 | $5.31K | Sell |
30
-12
| -29% | -$2.13K | ﹤0.01% | 1789 |
|
|
2023
Q2 | $7.98K | Buy |
42
+23
| +121% | +$4.37K | ﹤0.01% | 1643 |
|
|
2023
Q1 | $3.81K | Buy |
19
+18
| +1,800% | +$3.61K | ﹤0.01% | 1803 |
|
|
2022
Q4 | $238 | Buy |
+1
| New | +$238 | ﹤0.01% | 1985 |
|
|
2022
Q1 | – | Sell |
-81
| Closed | -$14K | – | 2026 |
|
|
2021
Q4 | $14K | Sell |
81
-5
| -6% | -$864 | ﹤0.01% | 1479 |
|
|
2021
Q3 | $16K | Buy |
86
+5
| +6% | +$930 | ﹤0.01% | 1313 |
|
|
2021
Q2 | $14K | Hold |
81
| – | – | ﹤0.01% | 1357 |
|
|
2021
Q1 | $11K | Buy |
+81
| New | +$11K | ﹤0.01% | 1305 |
|
|
2020
Q2 | – | Sell |
-296
| Closed | -$32K | – | 1489 |
|
|
2020
Q1 | $32K | Hold |
296
| – | – | ﹤0.01% | 919 |
|
|
2019
Q4 | $34K | Buy |
+296
| New | +$34K | ﹤0.01% | 1061 |
|
|
2019
Q1 | – | Sell |
-1,000
| Closed | -$73K | – | 1538 |
|
|
2018
Q4 | $73K | Buy |
+1,000
| New | +$73K | ﹤0.01% | 736 |
|
|
2013
Q4 | – | Sell |
-2,750
| Closed | -$176K | – | 1708 |
|
|
2013
Q3 | $176K | Sell |
2,750
-250
| -8% | -$16K | 0.01% | 712 |
|
|
2013
Q2 | $93K | Buy |
+3,000
| New | +$93K | ﹤0.01% | 873 |
|